Comparative study of patients with central serous chorioretinopathy undergoing focal laser photocoagulation or photodynamic therapy

The British Journal of Ophthalmology
Ji Won LimSeung Woo Lee

Abstract

To compare clinical outcomes for patients with central serous chorioretinopathy (CSC) undergoing either focal laser photocoagulation or photodynamic therapy (PDT). 26 eyes of 26 patients with symptomatic CSC underwent focal laser photocoagulation or half-dose PDT, as appropriate. Best-corrected visual acuity, optical coherence tomography and multifocal electroretinography were assessed prospectively prior to treatment and at 1, 3 and 6 months after treatment. 12 eyes in the focal laser group and 14 eyes in the PDT group were evaluated. One month after PDT, all eyes, except one, showed complete absorption of subretinal fluid, whereas five eyes in the focal laser group showed residual subretinal fluid (p=0.022). Visual acuity and parameters of multifocal electroretinography improved from baseline at 1, 3 and 6 months after treatment, without any significant differences between the two groups. However, compared with those in the PDT group at 1 month after treatment, P1 latencies in the first annuli of the focal laser group were delayed (40.1 ± 5.5 ms and 34.9 ± 2.5 ms, respectively; p=0.047). Compared with focal laser, half-dose PDT may facilitate earlier resolution of macular detachment and earlier recovery of central retinal fun...Continue Reading

Citations

Nov 18, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M MaierC P Lohmann
Feb 8, 2013·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Helena VasconcelosRufino Silva
Sep 29, 2011·Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·M Töteberg-HarmsR Windisch
Feb 16, 2013·Survey of Ophthalmology·Benjamin NicholsonCatherine Meyerle
Apr 10, 2015·Ophthalmic Surgery, Lasers & Imaging Retina·Leonardo MastropasquaPaolo Carpineto
Nov 21, 2015·Saudi Journal of Ophthalmology : Official Journal of the Saudi Ophthalmological Society·Marwan A Abouammoh
Jul 14, 2012·Clinical & Experimental Ophthalmology·Godfrey QuinSamantha Fraser-Bell
Jul 14, 2012·Clinical & Experimental Ophthalmology·Gerald LiewSamantha Fraser-Bell
Sep 12, 2012·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Kyoko FujitaMitsuko Yuzawa
Jun 1, 2015·Progress in Retinal and Eye Research·Alejandra DaruichFrancine Behar-Cohen
Jan 4, 2015·American Journal of Ophthalmology·Chiara M EandiFederico M Grignolo
Dec 23, 2015·The Cochrane Database of Systematic Reviews·Mahsa SalehiPeter Gehlbach
Jan 25, 2019·Current Pharmaceutical Design·Pierluigi IaconoMaria Cristina Parravano
Sep 1, 2012·Asia-Pacific Journal of Ophthalmology·David T LiuDennis S C Lam
Aug 31, 2016·International Ophthalmology Clinics·Nisreen S EzuddinChristina Y Weng
Aug 18, 2018·Experimental and Therapeutic Medicine·Qiang ZhangChangxia Dong
Nov 2, 2017·The British Journal of Ophthalmology·Xinghong SunQinghuai Liu
Jun 8, 2018·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Bert MüllerAntonia M Joussen
Aug 29, 2020·Case Reports in Ophthalmological Medicine·Prashanth G IyerHarry W Flynn
Nov 6, 2020·Pharmaceuticals·Maurizio Battaglia ParodiFrancesco Bandello
Sep 7, 2020·Archivos de la Sociedad Española de Oftalmología·F J Moreno-MorilloJ Donate-López
Sep 29, 2021·Indian Journal of Ophthalmology·Piyush KohliKim Ramasamy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.